Argatroban-6,
74874-10-5,
(2R,4R)-1-[(2S)-5-[[IMINO(NITROAMINO)METHYL]AMINO]-2-[[(3-METHYL-8-QUINOLINYL)SULFONYL]AMINO]-1-OXOPENTYL]-4-METHYL-2-PIPERIDINECARBOXYLIC ACID,
N-Nitro-1,2,3,4-tetradehydro Argatroban,
C23H31N7O7S,
1641AC,
AKOS016010211,
RL04846,
AX8078332,
FT-0673008,
J-523739,
[2R-[1(S*),2a,4?]-1-[5-[[iMino(nitroaMino)Methyl]aMino]-2-[[(3-Methyl-8-,
(2R,4R)-4-methyl-1-(N2-((3-methylquinolin-8-yl)sulfonyl)-Nw-nitro-L-arginyl)piperidine-2-carboxylic acid,
[2R-[1(S*),2|A,4|A]]-1-[5-[[Imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid,
Argatroban intermediates E,
2-Piperidinecarboxylic acid, 1-[(2S)-5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-, (2R,4R)-,